Multiple myeloma: open trials in Australia

52 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT05583617
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
St Vincent's Hospital Melbourne, Fitzroy · Prince of Wales Hospital, Randwick
Registry updated 2026-11-05
NCT05927571
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Trial Treatment · Phase 1 · Genentech, Inc.
Royal Adelaide Hospital;Haematology Clinical Trials Unit, Adelaide · Royal Prince Alfred Hospital, Camperdown · St Vincent's Hospital Melbourne, Melbourne · The Alfred Hospital, Prahan · Calvary Mater Newcastle, Waratah
Registry updated 2026-11-05
NCT07455851
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Royal Adelaide Hospital, Adelaide · St Vincents Hospital Melbourne, Fitzroy · South Western Sydney Local Health District - Liverpool Hosptial, Liverpool · Peter MacCallum Cancer Centre, Melbourne · Alfred Hospital, Melbourne · Prince of Wales Hospital, Randwick · Illawarra Cancer care centre, Wollongong Hospital, Wollongong
Registry updated 2026-11-05
NCT07222761
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Royal Adelaide Hospital, Adelaide · Pindara Private Hospital, Benowa · Mater Misericordiae Ltd., Brisbane · Epworth Freemasons, East Melbourne · Austin Hospital, Heidelberg · Alfred Hospital, Melbourne · Royal Perth Hospital, Perth · Gold Coast Hospital and Health Service, Southport
Registry updated 2026-11-04
NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Royal Prince Alfred Hospital, Camperdown · Barwon Health - University Hospital Geelong, Geelong · Liverpool Hospital, Liverpool · Sir Charles Gairdner Hospital, Nedlands · Calvary Mater Newcastle Hospital, New South Wales · Wollongong Hospital, Wollongong · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-11-03
NCT07149857
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Royal Prince Alfred Hospital, Camperdown · Monash Medical Centre, Clayton · Austin Hospital, Heidelberg · Fiona Stanley Hospital, Murdoch · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-11-03
NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Box Hill Hospital, Box Hill · Mater Misericordiae Ltd., Brisbane · Monash Medical Centre, Clayton · St Vincents Hospital Melbourne, Fitzroy · The Alfred Hospital, Melbourne · Fiona Stanley Hospital, Murdoch · Sir Charles Gairdner Hospital, Nedlands · Gold Coast University Hospital, Southport
Registry updated 2026-11-03
NCT07589634
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Flinders Medical Centre, Bedford Park · Sunshine Coast University Hospital, Birtinya · Concord Repatriation General Hospital, Concord · St Vincents Hospital Melbourne, Fitzroy · Wollongong Hospital, Wollongong
Registry updated 2026-11-03
NCT07665450
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
St Vincent's Hospital Sydney, Darlinghurst · Mater Hospital Brisbane, South Brisbane
Registry updated 2026-11-03
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Celgene
Birtinya · Box Hill · Liverpool · Melbourne · Melbourne · Nedlands · Waratah · Wollongong
Registry updated 2026-10-30
NCT06106945
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Trial Treatment · Phase 1/2 · AstraZeneca
Fitzroy · Melbourne · Nedlands · Wollongong
Registry updated 2026-10-30
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Adelaide · Brisbane · Camperdown · Clayton · Liverpool · Melbourne · Melbourne · Murdoch
Registry updated 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
Pindara Private Hospital, Benowa · Royal Prince Alfred Hospital, Camperdown · St Vincent's Hospital Melbourne, Fitzroy · Epworth Freemasons, Melbourne · The Alfred Hospital, Melbourne · Epworth Healthcare, Richmond
Registry updated 2026-10-27
NCT06953960
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Trial Treatment · Phase 1/2 · AbbVie
St Vincent's Hospital - Melbourne /ID# 271997, Fitzroy · Liverpool Hospital /ID# 272002, Liverpool · Epworth HealthCare /ID# 272497, Richmond · Calvary Mater Newcastle /ID# 272498, Waratah
Registry updated 2026-10-27
NCT04973605
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Trial Treatment · Phase 1/2 · BeOne Medicines
Monash Health, Clayton · St Vincents Hospital Melbourne, Fitzroy · Canberra Hospital, Garran · Nepean Hospital, Kingswood · The Alfred Hospital, Melbourne · Royal Perth Hospital, Perth
Registry updated 2026-10-26
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Trial Treatment · Phase 3 · AstraZeneca
Brisbane · Camperdown · Darlinghurst · East Melbourne · Fitzroy · Melbourne · Nedlands · Westmead
Registry updated 2026-10-21
NCT04910568
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 1 · Genentech, Inc.
The Alfred Hospital, Melbourne · Peter MacCallum Cancer Centre, Melbourne
Registry updated 2026-10-20
NCT06892522
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Trial Treatment · Phase 1/2 · AbbVie
Royal Adelaide Hospital /ID# 272629, Adelaide · Coffs Harbour Health Campus /ID# 272010, Coffs Harbour · St Vincent's Hospital - Melbourne /ID# 276451, Fitzroy · Peter MacCallum Cancer Centre. /ID# 272024, Melbourne · Port Macquarie Base Hospital /ID# 275925, Port Macquarie · Icon Cancer Care - South Brisbane /ID# 271836, South Brisbane · Westmead Hospital /ID# 271880, Westmead · The Perth Blood Institute - West Perth /ID# 272469, West Perth
Registry updated 2026-10-19
NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Trial Treatment · Phase 2 · Sanofi
Blacktown · Heidelberg · Melbourne · Richmond · Saint Leonards · Wollongong
Registry updated 2026-10-15
NCT07681596
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 1/2 · AstraZeneca
Camperdown · East Melbourne
Registry updated 2026-10-15
NCT04643002
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Trial Treatment · Phase 1/2 · Sanofi
Melbourne · Richmond · Wollongong
Registry updated 2026-10-13
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Trial Treatment · Phase 3 · Takeda
Royal Adelaide Hospital, Adelaide · Townsville Hospital, Douglas · Greenslopes Private Hospital, Greenslopes · St George Private Hospital, Kogarah · St Vincents Hospital Melbourne, Melbourne · Fiona Stanley Hospital, Murdoch · Western Health Sunshine Hospital, St Albans
Registry updated 2026-10-13
NCT07555938
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Trial Treatment · Phase 3 · Hoffmann-La Roche
St Vincent's Hospital Melbourne, Fitzroy · The Alfred Hospital, Melbourne
Registry updated 2026-10-13
NCT07558915
A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 1 · Genentech, Inc.
Peter MacCallum Cancer Center, Parkville
Registry updated 2026-10-09
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Trial Treatment · Phase 3 · European Myeloma Network B.V.
Flinders Medical Centre, Adelaide · Sunshine Coast Health, Birtinya · Townsville University Hospital, Douglas · Barwon Health University Hospital Geelong Andrew Love Cancer Centre, Geelong · Austin Health, Melbourne · Alfred Hospital, Melbourne · Calvary Mater Hospital, Newcastle · Concord Repatriation General Hospital, Sydney · Royal North Shore Hospital, Sydney
Registry updated 2026-10-07

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error